Completed PHASE3 INTERVENTIONAL 3-arm NCT00251693

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg Once- Daily [QD] and 90 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis

Sponsor: Takeda

Conditions Esophagitis, Peptic Esophagitis, Reflux

Interventions Dexlansoprazole MR Lansoprazole

Updated 7 times since 2017 Last updated: Feb 1, 2012 Started: Dec 31, 2005 Primary completion: Jan 31, 2007 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00251693, this PHASE3 trial focuses on Esophagitis, Peptic and Esophagitis, Reflux and remains completed. Sponsored by Takeda, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Takeda

Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alabaster, United States , Anaheim, United States , Arlington Heights, United States , Atlanta, United States , Austin, United States , Beachwood, United States , Beaumont, United States , Beaver Falls, United States , Binghamton, United States , Birmingham, United States and 130 more locations